{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:08:16Z","timestamp":1784185696101,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The incidence of LNM and survival outcomes following routine lymph node dissection (LND) in patients undergoing resection of hepatocellular carcinoma (HCC), intrahepatic- (ICC) and perihilar cholangiocarcinoma (PCC) has not been well-defined. This systematic review and meta-analysis analyzes the incidence of LNM and survival outcomes following routine LND independently of pre-or intraoperative suspicion of LNM following resection of HCC, ICC, and PCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The PubMed database was searched from database inception until March, 2025. Random-effects meta-analysis of the incidence of LNM and hazard ratios (HRs) of overall survival (OS) were conducted for each malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty studies were included. Routine LND was performed in 5 872 patients. The pooled incidence of LNM following routine LND was 5% among 601 HCC patients, 37% among 2 565 ICC patients, and 39% among 2 706 PCC patients. Presence of LNM was associated with worse OS in ICC (HR: 2.46, 95% CI 1.66\u20133.65) and PCC (HR: 2.01, 95% CI 1.74\u20132.33) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Routine LND should be performed during resection of ICC and PCC due to the high incidence of LNM and improved survival outcomes, but not during resection of HCC. The presence of LNM gives inferior survival outcomes in ICC and PCC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12029-026-01516-9","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:37:44Z","timestamp":1784180264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Routine Lymph Node Dissection in the Surgical Treatment of Primary Liver Tumors: a Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Britte L.","family":"Buisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Goense","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik J. H.","family":"Hoogwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten W.","family":"Nijkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inne H. M.","family":"Borel Rinkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Hagendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelmer E.","family":"Oor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"2","key":"1516_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3350\/cmh.2023.0070","volume":"29","author":"JH Oh","year":"2023","unstructured":"Oh JH, Jun DW. The latest global burden of liver cancer: A past and present threat. Clin Mol Hepatol. 2023;29(2):355\u20137.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"1516_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(2):127\u201340.","journal-title":"Ann Oncol"},{"issue":"3","key":"1516_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.suc.2020.02.013","volume":"100","author":"JC Mejia","year":"2020","unstructured":"Mejia JC, Pasko J. Primary Liver Cancers: Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Surg Clin North Am. 2020;100(3):535\u201349.","journal-title":"Surg Clin North Am"},{"issue":"12","key":"1516_CR4","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1007\/s11605-014-2667-1","volume":"18","author":"N Amini","year":"2014","unstructured":"Amini N, Ejaz A, Spolverato G, et al. Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review. J Gastrointest Surg. 2014;18(12):2136\u201348.","journal-title":"J Gastrointest Surg"},{"issue":"15","key":"1516_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","journal-title":"N Engl J Med"},{"issue":"24","key":"1516_CR6","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.3390\/cancers13246260","volume":"13","author":"AM van Keulen","year":"2021","unstructured":"van Keulen AM, Olthof PB, Cescon M, Guglielmi A, et al. Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure? Cancers (Basel). 2021;13(24):6260.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1516_CR7","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.3390\/cancers14102389","volume":"14","author":"LE Nooijen","year":"2022","unstructured":"Nooijen LE, Banales JM, de Boer MT, et al. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers (Basel). 2022;14(10):2389.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"1516_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21037\/cco.2018.07.03","volume":"7","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52.","journal-title":"Chin Clin Oncol"},{"issue":"2","key":"1516_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.hpb.2023.11.007","volume":"26","author":"M Yeow","year":"2024","unstructured":"Yeow M, Fong KY, Zhao JJ, et al. Value of lymph node dissection in intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. HPB (Oxford). 2024;26(2):161\u201370.","journal-title":"HPB (Oxford)"},{"issue":"9","key":"1516_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s10147-021-01967-z","volume":"26","author":"L Liang","year":"2021","unstructured":"Liang L, Li C, Wang MD, et al. The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis. Int J Clin Oncol. 2021;26(9):1575\u201386.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"1516_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejso.2021.08.009","volume":"48","author":"C Sposito","year":"2022","unstructured":"Sposito C, Droz Dit Busset M, Virdis M, et al. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review. Eur J Surg Oncol. 2022;48(1):150\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"1516_CR12","doi-asserted-by":"publisher","first-page":"957792","DOI":"10.3389\/fonc.2022.957792","volume":"12","author":"F Li","year":"2022","unstructured":"Li F, Jiang Y, Jiang L, et al. Effect of lymph node resection on prognosis of resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Front Oncol. 2022;12:957792.","journal-title":"Front Oncol"},{"issue":"11","key":"1516_CR13","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.4251\/wjgo.v15.i11.2017","volume":"15","author":"M Atif","year":"2023","unstructured":"Atif M, Borakati A, Mavroeidis VK. Role of routine lymph node dissection alongside resection of intrahepatic cholangiocarcinoma: Systematic review and meta-analysis. World J Gastrointest Oncol. 2023;15(11):2017\u201332.","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"1516_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. JAMA Surg. 2014;149(6):565\u201374.","journal-title":"JAMA Surg"},{"issue":"4","key":"1516_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.amjsurg.2015.05.015","volume":"210","author":"P Kambakamba","year":"2015","unstructured":"Kambakamba P, Linecker M, Slankamenac K, et al. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review. Am J Surg. 2015;210(4):694\u2013701.","journal-title":"Am J Surg"},{"issue":"2","key":"1516_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jhep.2022.10.021","volume":"78","author":"C Sposito","year":"2023","unstructured":"Sposito C, Ratti F, Cucchetti A, et al. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol. 2023;78(2):356\u201363.","journal-title":"J Hepatol"},{"issue":"4","key":"1516_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ejso.2022.11.008","volume":"49","author":"C Chen","year":"2023","unstructured":"Chen C, Su J, Wu H, et al. Prognostic value of lymphadenectomy in node-negative intrahepatic cholangiocarcinoma: A multicenter, retrospectively study. Eur J Surg Oncol. 2023;49(4):780\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"1516_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.surg.2019.06.025","volume":"166","author":"T Yoh","year":"2019","unstructured":"Yoh T, Cauchy F, Le Roy B, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study. Surgery. 2019;166(6):975\u201382.","journal-title":"Surgery"},{"key":"1516_CR19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1516_CR20","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"1516_CR21","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JAC Sterne","year":"2016","unstructured":"Sterne JAC, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"1516_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.","journal-title":"Trials"},{"issue":"6","key":"1516_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/MCG.0000000000000277","volume":"49","author":"X Wu","year":"2015","unstructured":"Wu X, Li B, Qiu J, et al. Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical Trial. J Clin Gastroenterol. 2015;49(6):520\u20138.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"1516_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s13304-010-0008-9","volume":"62","author":"M Ravaioli","year":"2010","unstructured":"Ravaioli M, Ercolani G, Grazi GL, et al. Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. Updates Surg. 2010;62(1):27\u201334.","journal-title":"Updates Surg"},{"issue":"5","key":"1516_CR25","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00268-010-0400-0","volume":"34","author":"S Xiaohong","year":"2010","unstructured":"Xiaohong S, Huikai L, Feng W, et al. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg. 2010;34(5):1028\u201333.","journal-title":"World J Surg"},{"key":"1516_CR26","doi-asserted-by":"crossref","unstructured":"Pan YJ, Wu SJ, Zeng Y et al. (2024) Intra- and Peri-tumoral Radiomics Based on Dynamic Contrast Enhanced-MRI to Identify Lymph Node Metastasis and Prognosis in Intrahepatic Cholangiocarcinoma. J Magn Reson Imaging. 2024;60(6):2669\u201380.","DOI":"10.1002\/jmri.29390"},{"issue":"6","key":"1516_CR27","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.hpb.2024.02.015","volume":"26","author":"Y Miura","year":"2024","unstructured":"Miura Y, Ashida R, Ohgi K, et al. Predictive score for identifying intrahepatic cholangiocarcinoma patients without lymph node metastasis: a basis for omitting lymph node dissection. HPB (Oxford). 2024;26(6):800\u20137.","journal-title":"HPB (Oxford)"},{"issue":"2","key":"1516_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jhep.2022.10.021","volume":"78","author":"C Sposito","year":"2023","unstructured":"Sposito C, Ratti F, Cucchetti A, et al. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol. 2023;78(2):356\u201363.","journal-title":"J Hepatol"},{"issue":"10","key":"1516_CR29","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00261-023-03991-1","volume":"48","author":"J Kolck","year":"2023","unstructured":"Kolck J, Auer TA, Walter-Rittel T, et al. Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it\u2019s not all about size. Abdom Radiol (NY). 2023;48(10):3063\u201371.","journal-title":"Abdom Radiol (NY)"},{"issue":"11","key":"1516_CR30","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1245\/s10434-022-12028-8","volume":"29","author":"S Zhang","year":"2022","unstructured":"Zhang S, Huang S, He W, et al. Radiomics-Based Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced Computed Tomography. Ann Surg Oncol. 2022;29(11):6786\u201399.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1516_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/jhbp.1038","volume":"29","author":"Y Umeda","year":"2022","unstructured":"Umeda Y, Mitsuhashi T, Kojima T, et al. Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: Inverse probability of treatment weighting with survival analysis. J Hepatobiliary Pancreat Sci. 2022;29(2):217\u201329.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"1516_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.surg.2021.12.026","volume":"172","author":"SH Kim","year":"2022","unstructured":"Kim SH, Han DH, Choi GH, et al. Prognostic impact of the metastatic lymph node number in intrahepatic cholangiocarcinoma. Surgery. 2022;172(1):177\u201383.","journal-title":"Surgery"},{"issue":"10","key":"1516_CR33","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00268-022-06655-1","volume":"46","author":"A Nassar","year":"2022","unstructured":"Nassar A, Tzedakis S, Sindayigaya R, et al. Factors of Early Recurrence After Resection for Intrahepatic Cholangiocarcinoma. World J Surg. 2022;46(10):2459\u201367.","journal-title":"World J Surg"},{"issue":"8","key":"1516_CR34","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.ejso.2019.04.019","volume":"45","author":"G Lurje","year":"2019","unstructured":"Lurje G, Bednarsch J, Czigany Z, et al. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2019;45(8):1468\u201378.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"1516_CR35","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1007\/s00330-019-06142-7","volume":"29","author":"GW Ji","year":"2019","unstructured":"Ji GW, Zhu FP, Zhang YD, et al. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma. Eur Radiol. 2019;29(7):3725\u201335.","journal-title":"Eur Radiol"},{"key":"1516_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jss.2018.01.024","volume":"226","author":"ZW Meng","year":"2018","unstructured":"Meng ZW, Lin XQ, Zhu JH, et al. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma. J Surg Res. 2018;226:56\u201363.","journal-title":"J Surg Res"},{"issue":"5","key":"1516_CR37","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4103\/jcrt.JCRT_356_17","volume":"13","author":"J Xiao","year":"2017","unstructured":"Xiao J, Zhu J, Liu Z, et al. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution. J Cancer Res Ther. 2017;13(5):756\u201360.","journal-title":"J Cancer Res Ther"},{"key":"1516_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fonc.2011.00042","volume":"1","author":"YX Chen","year":"2011","unstructured":"Chen YX, Zeng ZC, Tang ZY, et al. Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases. Front Oncol. 2011;1:42.","journal-title":"Front Oncol"},{"issue":"6","key":"1516_CR39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00268-005-7761-9","volume":"29","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa T, Kamiyama T, Kurauchi N, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2005;29(6):728\u201333.","journal-title":"World J Surg"},{"issue":"11","key":"1516_CR40","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1046\/j.0007-1323.2001.01879.x","volume":"88","author":"M Shimada","year":"2001","unstructured":"Shimada M, Yamashita Y, Aishima S, et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88(11):1463\u20136.","journal-title":"Br J Surg"},{"issue":"2","key":"1516_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s005340050094","volume":"6","author":"A Valverde","year":"1999","unstructured":"Valverde A, Bonhomme N, Farges O, et al. Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg. 1999;6(2):122\u20137.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"3","key":"1516_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jjco\/29.3.147","volume":"29","author":"M Yamamoto","year":"1999","unstructured":"Yamamoto M, Takasaki K, Yoshikawa T. Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol. 1999;29(3):147\u201350.","journal-title":"Jpn J Clin Oncol"},{"key":"1516_CR43","first-page":"14","volume":"2","author":"AN Polyakov","year":"2024","unstructured":"Polyakov AN, Patyutko YI, Kotelnikov AG, et al. Surgical treatment and prognostic factors in perihilar tumors. Khirurgiia (Mosk). 2024;2:14\u201323.","journal-title":"Khirurgiia (Mosk)"},{"issue":"4","key":"1516_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jhbp.1387","volume":"31","author":"F Terasaki","year":"2024","unstructured":"Terasaki F, Sugiura T, Okamura Y, et al. Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations. J Hepatobiliary Pancreat Sci. 2024;31(4):251\u201361.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"5","key":"1516_CR45","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s11605-021-05211-x","volume":"26","author":"ZP Liu","year":"2022","unstructured":"Liu ZP, Zhang QY, Chen WY, et al. Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma. J Gastrointest Surg. 2022;26(5):1030\u201340.","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"1516_CR46","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11605-019-04244-7","volume":"24","author":"WJ Ma","year":"2020","unstructured":"Ma WJ, Wu ZR, Hu HJ, et al. Extended Lymphadenectomy Versus Regional Lymphadenectomy in Resectable Hilar Cholangiocarcinoma. J Gastrointest Surg. 2020;24(7):1619\u201329.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"1516_CR47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.surg.2017.03.017","volume":"162","author":"N Kimura","year":"2017","unstructured":"Kimura N, Young AL, Toyoki Y, Wyatt JI, et al. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. Surgery. 2017;162(3):500\u201314.","journal-title":"Surgery"},{"issue":"10","key":"1516_CR48","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/jamasurg.2016.1769","volume":"151","author":"F Giuliante","year":"2016","unstructured":"Giuliante F, Ardito F, Guglielmi A, et al. Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis. JAMA Surg. 2016;151(10):916\u201322.","journal-title":"JAMA Surg"},{"issue":"Suppl 3","key":"1516_CR49","doi-asserted-by":"publisher","first-page":"S1107","DOI":"10.1245\/s10434-015-4723-9","volume":"22","author":"HT Mantel","year":"2015","unstructured":"Mantel HT, Wiggers JK, Verheij J, et al. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma. Ann Surg Oncol. 2015;22(Suppl 3):S1107\u201315.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1516_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/hpb.12296","volume":"17","author":"JM Regimbeau","year":"2015","unstructured":"Regimbeau JM, Fuks D, Pessaux P, et al. Tumour size over 3\u00a0cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group. HPB (Oxford). 2015;17(1):79\u201386.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"1516_CR51","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s00268-013-2394-x","volume":"38","author":"N Furusawa","year":"2014","unstructured":"Furusawa N, Kobayashi A, Yokoyama T, et al. Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg. 2014;38(5):1164\u201376.","journal-title":"World J Surg"},{"key":"1516_CR52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1477-7819-10-106","volume":"10","author":"T Noji","year":"2012","unstructured":"Noji T, Miyamoto M, Kubota KC, et al. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol. 2012;10:106.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"1516_CR53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jamcollsurg.2012.05.025","volume":"215","author":"K Matsuo","year":"2012","unstructured":"Matsuo K, Rocha FG, Ito K, et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012;215(3):343\u201355.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"1516_CR54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000327361","volume":"28","author":"H Li","year":"2011","unstructured":"Li H, Qin Y, Cui Y, et al. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg. 2011;28(3):226\u201331.","journal-title":"Dig Surg"},{"issue":"3","key":"1516_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1245\/s10434-010-1325-4","volume":"18","author":"Y Murakami","year":"2011","unstructured":"Murakami Y, Uemura K, Sudo T, et al. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol. 2011;18(3):651\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1516_CR56","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/bjs.6618","volume":"96","author":"XP Chen","year":"2009","unstructured":"Chen XP, Lau WY, Huang ZY, et al. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg. 2009;96(10):1167\u201375.","journal-title":"Br J Surg"},{"issue":"6","key":"1516_CR57","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s00268-007-9001-y","volume":"31","author":"S Hasegawa","year":"2007","unstructured":"Hasegawa S, Ikai I, Fujii H, et al. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007;31(6):1256\u201363.","journal-title":"World J Surg"},{"issue":"11","key":"1516_CR58","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1445-2197.2005.03595.x","volume":"75","author":"EC Lai","year":"2005","unstructured":"Lai EC, Lau WY. Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg. 2005;75(11):981\u20135.","journal-title":"ANZ J Surg"},{"issue":"1","key":"1516_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.coc.0000139017.90599.f5","volume":"28","author":"DE Stein","year":"2005","unstructured":"Stein DE, Heron DE, Rosato EL, et al. Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol. 2005;28(1):21\u20133.","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"1516_CR60","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/archsurg.139.5.514","volume":"139","author":"DJ Rea","year":"2004","unstructured":"Rea DJ, Munoz-Juarez M, Farnell MB, Donohue JH, et al. Major Hepatic Resection for Hilar Cholangiocarcinoma: Analysis of 46 Patients. Arch Surg. 2004;139(5):514\u201325.","journal-title":"Arch Surg"},{"issue":"1","key":"1516_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.SLA.0000074960.55004.72","volume":"238","author":"Y Seyama","year":"2003","unstructured":"Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238(1):73\u201383.","journal-title":"Ann Surg"},{"issue":"3","key":"1516_CR62","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/00000658-200103000-00013","volume":"233","author":"Y Kitagawa","year":"2001","unstructured":"Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233(3):385\u201392.","journal-title":"Ann Surg"},{"issue":"4","key":"1516_CR63","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/ans.15096","volume":"89","author":"A Yang","year":"2019","unstructured":"Yang A, Xiao W, Ju W, et al. Prevalence and clinical significance of regional lymphadenectomy in patients with hepatocellular carcinoma. ANZ J Surg. 2019;89(4):393\u20138.","journal-title":"ANZ J Surg"},{"key":"1516_CR64","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.hpb.2025.12.039","volume":"28","author":"G Waller","year":"2026","unstructured":"Waller G, Takahashi H, Bekki Y, et al. Perihilar cholangiocarcinoma: microscopic positive margin and its clinical relevance. HPB. 2026;28:574\u201381.","journal-title":"HPB"},{"issue":"4","key":"1516_CR65","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.amjsurg.2015.05.015","volume":"210","author":"P Kambakamba","year":"2015","unstructured":"Kambakamba P, Linecker M, Slankamenac K, et al. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review. Am J Surg. 2015;210(4):694\u2013701.","journal-title":"Am J Surg"},{"key":"1516_CR66","doi-asserted-by":"publisher","DOI":"10.1055\/a-2366-2592","author":"DM de Jong","year":"2024","unstructured":"de Jong DM, van de Vondervoort S, Dwarkasing RS et al. Endoscopic Ultrasound with Tissue Acquisition of Lymph Nodes in Patients with Potentially Resectable Intrahepatic Cholangiocarcinoma. Endoscopy Int Open 2024. https:\/\/doi.org\/10.1055\/a-2366-2592","journal-title":"Endoscopy Int Open"},{"issue":"1","key":"1516_CR67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40644-023-00626-y","volume":"23","author":"J Zhang","year":"2023","unstructured":"Zhang J, Jiang S, Li M, et al. Head-to-head comparison of 18F-FAPI and 18F-FDG PET\/CT in staging and therapeutic management of hepatocellular carcinoma. Cancer Imaging. 2023;23(1):106.","journal-title":"Cancer Imaging"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01516-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01516-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01516-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:02:45Z","timestamp":1784185365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01516-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01516-9","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"this review used data from published studies and therefore no ethics approval was required.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"154"}}